Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report

Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y.

Medicine (Baltimore). 2019 Jun;98(26):e16163. doi: 10.1097/MD.0000000000016163.

Photosensitive Melanopsin-Containing Retinal Ganglion Cells in Health and Disease: Implications for Circadian Rhythms

Lax P, Ortuño-Lizarán I, Maneu V, Vidal-Sanz M, Cuenca N.

Int J Mol Sci. 2019 Jun 28;20(13):3164. doi: 10.3390/ijms20133164.

Oligomeric α-synuclein is increased in basal tears of Parkinson's patients

Hamm-Alvarez SF, Okamoto CT, Janga SR, Feigenbaum D, Edman MC, Freire D, Shah M, Ghanshani R, Mack WJ, Lew MF.

Biomark Med. 2019 Aug;13(11):941-952. doi: 10.2217/bmm-2019-0167. Epub 2019 Jul 2.

Delayed recovery from neuromuscular block after sugammadex in a patient with Parkinson's disease

Altıparmak B, Korkmaz Toker M, Uysal A, Pınarbaşı A, Gümüş Demirbilek S.

Br J Anaesth. 2019 Sep;123(3):e459-e460. doi: 10.1016/j.bja.2019.06.002. Epub 2019 Jun 28.

Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease

Barker RA; TRANSEURO consortium.

Nat Med. 2019 Jul;25(7):1045-1053. doi: 10.1038/s41591-019-0507-2. Epub 2019 Jul 1.

The Central Autonomic Network and Regulation of Bladder Function

Roy HA, Green AL.

Front Neurosci. 2019 Jun 13;13:535. doi: 10.3389/fnins.2019.00535. eCollection 2019.

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies

Refolo V, Stefanova N.

Front Cell Neurosci. 2019 Jun 13;13:263. doi: 10.3389/fncel.2019.00263. eCollection 2019.

State of the art in human adipose stem cells and their role in therapy

Şovrea AS, Boşca AB, Constantin AM, Dronca E, Ilea A.

Rom J Morphol Embryol. 2019;60(1):7-31.

Parkinson's disease biomarkers based on α-synuclein

Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B, El-Agnaf OMA.

J Neurochem. 2019 Sep;150(5):626-636. doi: 10.1111/jnc.14809. Epub 2019 Jul 28.

Cellular models of alpha-synuclein toxicity and aggregation

Delenclos M, Burgess JD, Lamprokostopoulou A, Outeiro TF, Vekrellis K, McLean PJ.

J Neurochem. 2019 Sep;150(5):566-576. doi: 10.1111/jnc.14806. Epub 2019 Jul 30.

A Randomized Controlled Trial to Investigate the Impact of Tango Argentino versus Tai Chi on Quality of Life in Patients with Parkinson Disease: A Short Report

Poier D, Rodrigues Recchia D, Ostermann T, Büssing A.

Complement Med Res. 2019;26(6):398-403. doi: 10.1159/000500070. Epub 2019 Jul 2.

Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester

Sarkar A, Rawat N, Sachan N, Singh MP.

Neurotox Res. 2019 Oct;36(3):627-644. doi: 10.1007/s12640-019-00080-4. Epub 2019 Jul 2.

Perioperative management of patients with genetic multisystem diseases associated with pre‑excitation

Staikou C, Stamelos M, Stavroulakis E.

Anaesthesiol Intensive Ther. 2019;51(2):133-146. doi: 10.5114/ait.2019.86278.

Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?

Guglielmi P, Carradori S, Ammazzalorso A, Secci D.

Expert Opin Drug Discov. 2019 Oct;14(10):995-1035. doi: 10.1080/17460441.2019.1637415. Epub 2019 Jul 3.

The physiological role of α-synuclein and its relationship to Parkinson's Disease

Sulzer D, Edwards RH.

J Neurochem. 2019 Sep;150(5):475-486. doi: 10.1111/jnc.14810. Epub 2019 Jul 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias